Past Issues

Go

Pursuing arcs of science at Duke-NUS

At a scientific symposium marking the School's 20th anniversary, researchers traced the journeys of discovery that shaped their careers and transformed medicine

Dr Chua Li Min, science writer

What transforms science from idea to impact?

At the “The arc of Duke-NUS science” symposium held in April, our anniversary month, 18 researchers from across Duke-NUS’ five signature research programmes and beyond came together to trace the miraculous journey of scientific exploration, bringing audience along winding arcs of discovery, with personal milestones intertwined with the School’s evolution over the past 20 years.

In this special feature, MEDICUS science writer Chua Li Min brings you highlights of the symposium, spotlighting researchers who have made it their mission to unravelling the human body’s complexities, exploring everything from individual proteins to whole organisms, disease pathologies, and even the intricate process of ageing.

Their stories show that what follows from an initial spark is a journey that unfolds across months—years and even entire careers—driven by purpose and the sense that every question and experiment offer hope of improving the life of someone, somewhere.

 

Angelique Chan

A force in ageing research
“We were the first ageing centre in an academic environment in Singapore, and I wanted it to be at Duke NUS, because this was the place where like-minded colleagues with both the technical and clinical skills were willing to collaborate in interdisciplinary research.”

Angelique Chan_ARC

 

When Associate Professor Angelique Chan returned to Singapore fresh from a postdoctoral degree in 1997, she was ready to dive into a thriving landscape of ageing research. Instead, what the gerontologist discovered was a surprising void.

“Singapore was ageing extremely fast. However, there was very little data on the determinants of health, well-being and transitions over the life course,” recalled Chan. “So the first thing that I did was to establish databases on ageing. My goal was to study how social factors impact older adults’ health.”  

That initial endeavour marked the beginning of Chan’s decade-long campaign to set up an academic centre dedicated to ageing research.

For Chan, there was no doubt that Duke-NUS would be the academic home for the centre, a decision she made after a 2008 sabbatical at the School. Her efforts paid off in 2015 with the launch of the Duke-NUS Centre for Ageing Research & Education (CARE).

“We were the first ageing centre in an academic environment in Singapore, and I wanted it to be at Duke NUS, because this was the place where like-minded colleagues with both the technical and clinical skills were willing to collaborate in interdisciplinary research,” explained Chan, who helmed the Centre as its executive director for the past 10 years before stepping down recently.

The CARE team in 2024 // Credit: Duke-NUS
The CARE team in 2024 // Credit: Duke-NUS

While the Centre may have begun with just two researchers Chan and associate professor Rahul Malhotra, it is now a 24-person strong team comprising multidisciplinary researchers. 

Since then, some of CARE’s landmark studies include evaluating how loneliness affects the life and health expectancies of older adults as well as the changing cohort characteristics of older persons—the insights of which have helped shape certain government policies.

“None of this would have been possible without the incredible team at CARE. We now have two national cohorts of older persons: a pioneer cohort and a cohort of younger elderly. We have earned research competitive funding of about $33 million and we’ll continue to use ever-improving research methods on the longitudinal data we have collected,” said Chan, as she reflected on the Centre’s progress.

“I’m excited for what’s ahead.”


 

Cao Mian

On a quest to rewire the brain’s lost connections

“Over the next 20 years, my goal is to deepen our understanding of the fundamental mechanisms underlying selective neuronal degeneration—one of the most challenging questions in the field, as well as to develop new disease models connecting basic and translational research.”

Cao Mian_ARC

 

Imagine the entire brain as a bustling central mail hub, comprised of networks of delivery routes. The letters that are sent via this elaborate system are how cells in the brain communicate. But what happens when these messages are scrambled or lost?

Visualising neurons and their synapses using specialised stains // Credit: Courtesy of Cao Mian
A close-up of dopamine neurons showing signs of degeneration at the synapses // Credit: Courtesy of Cao Mian

These defects in the brain’s messaging system are often the earliest signs of disease, making it a valuable window for early diagnosis and treatment, explained Cao Mian, an assistant professor with Duke-NUS’ Neuroscience and Behavioural Disorders programme. “That’s what contributes to neurodegenerative diseases such as Parkinson’s disease,” he added.

In Parkinson’s disease, a subset of brain cells, otherwise known as dopamine-producing neurons die off, causing symptoms such as tremors and rigidity in patients.

To understand what causes these defects, Cao is diving into the mechanisms of this intricate process which takes place at the synapses, junctions that exist between neurons.

Cao pictured here with his lab // Credit: Courtesy of Cao Mian
Cao pictured here with his lab // Credit: Courtesy of Cao Mian

Known as synaptic membrane trafficking, this process has kept him fascinated for years, a path Cao decided to embark on during his postdoctoral training, when his collaborator identified the first Parkinson’s disease-associated mutation in the SYNJ1 gene that regulates this critical step.

“That experience sparked my long-term interest in how impaired synaptic membrane trafficking drives disease mechanisms in neurodegeneration,” explained Cao. “By studying these early cellular disruptions, we can uncover shared disease pathways and potentially develop broader therapeutic strategies.” 

That is what Cao hopes to do and more.

“Over the next 20 years, my goal is to deepen our understanding of the fundamental mechanisms underlying selective neuronal degeneration—one of the most challenging questions in the field, as well as to develop new disease models connecting basic and translational research. Through this, I hope to identify early biomarkers and drug targets to enable earlier diagnosis and more effective interventions.”


 

Thomas Coffman

Tackling diabetic kidney disease 

“So we put together a team focused on understanding the root causes of the disease—to address the unmet need for new therapies and for stratifying risk among patients with diabetes.”

Thomas Coffman_ARC

 

For patients with diabetes, managing high blood sugar is just one part of their struggle. Some grapple with ailing kidneys that lead to kidney failure, adding a devastating layer to an already complex disease.

With two in three new cases of kidney failure in Singapore caused by diabetes, “it’s a huge problem with a big unmet need. This is why early detection and timely institution of treatments are most critical,” said Thomas Coffman, a nephrologist by training and professor from the Duke-NUS Cardiovascular and Metabolic Disorders Programme.  

“So we put together a team focused on understanding the root causes of the disease—to address the unmet need for new therapies and for stratifying risk among patients with diabetes,” added Coffman, who is also Dean of Duke-NUS. 

That urgency led to the creation of DYNAMO (the Diabetes Study in Nephropathy And other Microvascular Complications)—a national research initiative founded under Coffman’s leadership.

Through their efforts, the team hopes to understand how and why diabetes damages the kidneys, and what can be done to stop it.

“We were the very first large collaborative grant to be funded,” recalled Coffman.

Just five years after receiving its initial funding of S$25 million in 2017, DYNAMO successfully established a large group of patient cohorts, yielding an invaluable data source to accelerate critical research.

From leveraging high-throughput technologies using an “omics” approach, the group has made headway in understanding the genes, proteins and metabolites involved in disease pathology through its five key research themes.

The DYNAMO team shares a photo after a meeting in 2024 // Credit: Courtesy of Thomas Coffman
The DYNAMO team shares a photo after a meeting in 2024 // Credit: Courtesy of Thomas Coffman

One major finding? Lactate, a by-product associated with post-exercise muscle aches, emerged as a strong indicator of kidney damage in patients with diabetes. “The higher the lactate level was, the greater a patient’s risk of developing kidney failure,” explained Coffman.

“So there is clearly a subset of patients that are at higher risk. And we hope to identify who they are so we can start randomising these patients to more intensive therapies and interventions,” he added.

With the grant’s renewal in 2023 for the second time, Coffman is optimistic about their journey ahead.

“We believe we are on the cusp of discoveries that will bring new hope to patients for opportunities to live full and healthy lives,” he concluded.  


 

Wang Linfa

Bat science takes flight 

“It’s incredible how far we’ve come. I started with a single question, and now we have the first world-class, specifically designed bat house at Duke-NUS. My greatest hope is to see this work continue to advance our understanding of bat biology.”

Wang Linfa_ARC

 

For nearly three decades, Professor Wang Linfa has pursued a deceptively simple question: Why bats?

Wang’s collaborations have also expanded beyond the little red dot, as he is also a member of the project, BATPROTECT // Credit: iStock.com / CreativeNature_nl
Wang’s collaborations have also expanded beyond the little red dot, as he is also a member of the project, BATPROTECT, which was awarded €11.9 million by the European Research Council Synergy Grant to understand how bats can resist diseases and live longer // Credit: iStock.com / CreativeNature_nl

That question–and a painting with the same title in his office—has powered a career exploring the biology of bats, their resistance to disease, and their role in emerging pandemics. It’s also earned him the nickname “Batman”.

In just one slide, Wang delivers a captivating breakdown of the amazing biology of bats, from his years of research at Duke-NUS’ Emerging Infectious Disease programme. The audience is left with a newfound appreciation for these winged mammals and their secrets.

It is of no surprise, then, that Wang’s mastery of bat biology has sealed his identity as Batman, a moniker he’s carried ever since his groundbreaking discovery that bats are reservoirs of emerging zoonotic viruses—pathogens which are capable of jumping from one species to another.

“We started asking why bats could carry such deadly viruses and don’t get sick,” explained Wang, who believes that understanding the mechanisms underlying this phenomenon could be key to unlocking life-changing treatments that better control viral infections, fight cancer and enable people to live longer.

“But here’s where it gets batty,” quipped Wang, recalling the challenge of convincing people of the potential impact of his research.

Wang with the five batty alumni who have graduated from his lab // Credit: Courtesy of Wang Linfa
Wang with the five batty alumni who have graduated from his lab // Credit: Courtesy of Wang Linfa

Ultimately, it was Wang’s conviction in his group’s ability to translate their work from bats to human health that won his group a S$10 million grant from the National Research Foundation Competitive Research Programme in 2013.

Since then, their discoveries—the latest of which include the identification of a powerful protein inhibitor of inflammation in bats ASC2—have led to the establishment of a biotech start-up, Paratus Sciences, in 2021 focused on developing bat immunology-inspired therapies, with a new class of anti-inflammatory drugs set to progress to Phase 1 clinical trials next year.

Reflecting on his journey, Wang said: “It’s incredible how far we’ve come. I started with a single question, and now we have the first world-class, specifically designed bat house at Duke-NUS. My greatest hope is to see this work continue to advance our understanding of bat biology.”

And with five batty MD-PhD students who’ve flown the “bat cave” and two still with his lab, Wang’s true legacy lies not just in his discoveries, but also in the scientific wings he has helped countless grow.

 


 

And the arc continues…

Session Chairperson, Professor David Virshup kickstarts the symposium with three epochs from the School’s history
Session Chairperson, Professor David Virshup kickstarts the symposium with three epochs from the School’s history
Assoc Prof Ashley St. John on her path to Duke-NUS in pursuit of research on mast cells and emerging infectious diseases
Associate Professor Ashley St John on her path to Duke-NUS in pursuit of research on mast cells and emerging infectious diseases 
Professor Chris Newgard looks back on his 20 years of interaction with Duke-NUS and the research collaborations forged
Professor Chris Newgard looks back on his 20 years of interaction with Duke-NUS and the research collaborations forged
How does one transform a cool idea into positive change? Health services systems researcher Professor David Matchar gives his insights
How does one transform a cool idea into positive change? Health services systems researcher Professor David Matchar gives his insights
They may be tiny, but they are mighty: Associate Professor Lena Ho retraces her quest to unlock the secrets of microproteins
They may be tiny, but they are mighty: Associate Professor Lena Ho retraces her quest to unlock the secrets of microproteins
Professor Mei-Wang Casey is going all in on a molecular key, isoprenylcysteine carboxyl methyltransferase, to unlock a path for treating cancer
Professor Mei-Wang Casey is going all in on a molecular key, isoprenylcysteine carboxyl methyltransferase, to unlock a path for treating cancer
Professor Ong Sin Tiong on how we might be one step closer to curing chronic myeloid leukaemia with predictive biomarkers
Professor Ong Sin Tiong on how we might be one step closer to curing chronic myeloid leukaemia with predictive biomarkers
Early architect of Duke-NUS Professor Pat Casey reflects on his time at Duke-NUS and how the School has evolved to become today’s research powerhouse
Early architect of Duke-NUS Professor Pat Casey reflects on his time at Duke-NUS and how the School has evolved to become today’s research powerhouse
Professor Patrick Tan and his team are zooming in on the molecular signatures of gastric cancer using a transformative RNA technology
Professor Patrick Tan and his team are zooming in on the molecular signatures of gastric cancer using a transformative RNA technology
What can a human brain in a dish teach us? Professor Shawn Je shares his journey in neuroscience research.
What can a human brain in a dish teach us? Professor Shawn Je shares his journey in neuroscience research. 
Flying in from Durham to the symposium stage, Emeritus Professor Shirish Shenolikar elaborates on the essential scientific skills for academics and industry in his talk on mentoring the next generation
Flying in from Durham to the symposium stage, Emeritus Professor Shirish Shenolikar elaborates on the essential scientific skills for academics and industry in his talk on mentoring the next generation
From receiving the STaR Investigator Award to his quest to develop novel therapies, Adjunct Professor Stuart Cook looks back on his journey in translational research
From receiving the STaR Investigator Award to his quest to develop novel therapies, Adjunct Professor Stuart Cook looks back on his journey in translational research

Get the latest news and features delivered to your inbox.

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser